In AML, carnitine palmitoyl transferase 1A (CPT1A), which catalyzes the rate-limiting step of FAO, and carnitine transporter CT2 (SLC22A16) are overexpressed and constitute novels targets for a subset of AML (50, 51). The gene discussed is SLC22A16; the disease is acute myeloid leukemia.